2017年第377卷25期
共23篇2. Tumor Mutational Burden and Response Rate to PD-1 Inhibition. 2500-2501页
作者:Mark,Yarchoan; Alexander,Hopkins; Elizabeth M,Jaffee
5. Hospital-Readmission Risk - Isolating Hospital Effects. 2504-5页
作者:Daniel J,Brotman; Erik,Hoyer; Amy,Deutschendorf
7. Putting the Patient Back Together - Social Medicine, Network Medicine, and the Limits of Reductionism. 2493-2499页
作者:Jeremy A,Greene; Joseph,Loscalzo
9. Hospital-Readmission Risk - Isolating Hospital Effects. 2505页
作者:Harlan M,Krumholz; Kun,Wang; Sharon-Lise T,Normand
11. Hospital-Readmission Risk - Isolating Hospital Effects. 2505页
作者:Yvo M,Smulders; Prabath W B,Nanayakkara
13. Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda. 2456-2464页
作者:Abhaya V,Kulkarni; Steven J,Schiff; Edith,Mbabazi-Kabachelor; John,Mugamba; Peter,Ssenyonga; Ruth,Donnelly; Jody,Levenbach; Vishal,Monga; Mallory,Peterson; Michael,MacDonald; Venkateswararao,Cherukuri; Benjamin C,Warf
14. Nivolumab and Ipilimumab in Advanced Melanoma. 2503页
作者:Emilio J,Alegre-del-Rey; Blanca,de la Nogal Fernández; Pilar,Briceño-Casado
15. Is There Merit in Merit Aid? 2415-2417页
作者:Roy C,Ziegelstein; Charles G,Prober; Lloyd B,Minor; George Q,Daley; Paul B,Rothman; Edward M,Hundert
17. Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes. 2502页
作者:Konstantinos P,Imprialos; Konstantinos,Stavropoulos; Michael,Doumas
18. Nivolumab and Ipilimumab in Advanced Melanoma. 2503-2504页
作者:Jedd D,Wolchok; Linda,Rollin; James,Larkin
20. Case 39-2017. A 41-Year-Old Woman with Recurrent Chest Pain. 2475-2484页
作者:Sarah V,Tsiaras; Lucy M,Safi; Brian B,Ghoshhajra; Mark E,Lindsay; Malissa J,Wood
21. Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes. 2502页
作者:Rury R,Holman; M Angelyn,Bethel; Adrian F,Hernandez